Arkolith/Insider Trading/WHWK/Form 4

Lennon David James

CHIEF EXECUTIVE OFFICER, DirectorWhitehawk Therapeutics, Inc. (WHWK) · full profile →Form 4 · filed Mar 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$17K
Net Open-Market Flow
-$17K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Sell(S)5K$3.31$17K45K
Mar 1, 2026Option exercise(M)16K——50K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 1, 2026Option exercise(M)16K—$033K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001995275-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML